Hetero`s Generic Eluxadoline Receives Approval in the U.S.
10 Aug 2023 //
FDA
Sun Pharma`s Generic Eluxadoline Receives Approval in the US
17 Nov 2021 //
FDA
Zydus Cadila receives tentative approval from US FDA for Eluxadoline tablets
15 Nov 2021 //
EXPRESS PHARMA
Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® Eluxadoline
10 Jul 2017 //
PR NEWSWIRE
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
16 Mar 2017 //
RAPS
Allergan CEO: 2017 should be Kybella`s breakout year
12 Jan 2017 //
FIERCE PHARMA
Fitch Affirms Allergan at `BBB-`; Outlook Stable
08 Dec 2016 //
REUTERS
Valeant looks to revive Xifaxan with primary care sales effort. Will it work?
02 Dec 2016 //
FIERCE PHARMA
Allergan teams with star paratriathlete in yet another effort to boost Viberzi
23 Nov 2016 //
FIERCE PHARMA
Allergan`s handling of Q3 `black eye` dings confidence in management: Analyst
03 Nov 2016 //
FIERCE PHARMA
Allergan snags tech partner for IBS-D platform
25 Oct 2016 //
FIERCE PHARMA
Aptalis Pharma`s Truberzi (Eluxadoline) Approved In Europe
29 Sep 2016 //
EUROPE
Allergan Receives Positive Opinion For Truberzi For Treatment Of IBS-D
25 Jul 2016 //
PR NEWSWIRE
Allergan`s stellar Viberzi coverage bodes well for future launches: Analyst
20 Jun 2016 //
FIERCE PHARMA
Allergan continues Viberzi push with online IBS-D awareness tool
26 May 2016 //
FIERCE PHARMA
Vexing IBS-D spokescharacter `Irritabelle` headlines Allergan`s Viberzi ad push
11 Apr 2016 //
FIERCE PHARMA MARKETING
VIBERZI PhIII Trial Results Published in The New England Journal of Medicine
21 Jan 2016 //
PR NEWSWIRE
Allergan’s Viberzi (eluxadoline) now available in the US
15 Dec 2015 //
EUROPEAN PHARMACEUTICAL REVIEW
Valeant`s wobbly pink `Gut Guy` for Xifaxan is getting noticed
14 Dec 2015 //
FIERCE PHARMA MARKETING
Allergan pumps up its sales rep tally amid Viberzi launch, aesthetics push
05 Nov 2015 //
FIERCE PHARMA MARKETING
Allergan`s H2 looks lighter without generics, but 10% growth on tap for 2016
30 Sep 2015 //
FIERCE PHARMA